Physician profile
Mark H Bell
NPI 1497755631
$8,987.97
in general payments reported to CMS, 2019-2025
37 companies · $1,146 in 2025
The $1,146 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,395 · 2020: $984 · 2021: $900 · 2022: $872 · 2023: $2,477 · 2024: $1,214 · 2025: $1,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,746 · Travel and Lodging: $1,091.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,745.52 |
| Travel and Lodging | $1,091.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,367.60 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Spectra Wavewriter |
| Tersera Therapeutics LLC | $543.41 | 2019-2025 | Prialt |
| Collegium Pharmaceutical, INC. | $373.57 | 2019-2025 | Xtampza, Belbuca |
| Curonix LLC | $364.81 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $339.60 | 2023-2024 | Vanta Adaptivestim, Intellis Adaptivestim |
| Si-Bone, INC. | $319.50 | 2019-2025 | |
| Nevro Corp. | $317.31 | 2019-2024 | Senza |
| Spr Therapeutics, INC | $242.74 | 2023-2025 | Sprint Pns System |
| Averitas Pharma INC. | $221.01 | 2023-2025 | Qutenza |
| Foundation Fusion Solutions, LLC | $177.70 | 2024-2025 | |
| Arbor Pharmaceuticals, INC. | $164.84 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $157.95 | 2022-2025 | Relistor |
| Abbvie INC. | $148.39 | 2022-2025 | Botox, Qulipta |
| Scilex Pharmaceuticals INC. | $114.24 | 2019 | |
| Globus Medical, INC. | $113.43 | 2025 | Senza |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $93.90 | 2021-2022 | |
| Medtronic USA, INC. | $83.13 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $74.95 | 2020-2021 | |
| Depuy Synthes Sales INC. | $71.91 | 2019-2023 | Orthovisc |
| Pacira Therapeutics, INC. | $71.54 | 2019-2021 | |
| Mdd US Operations, LLC | $63.42 | 2019-2020 | |
| Acelrx Pharmaceuticals, INC. | $55.05 | 2019 | |
| Almatica Pharma LLC | $51.79 | 2022 | |
| Grt US Holding, INC. | $49.58 | 2022 | |
| Bioventus LLC | $46.97 | 2022-2025 | Durolane |
| Pacira Pharmaceuticals Incorporated | $46.46 | 2023-2024 | Iovera, Zilretta, Exparel |
| Biotronik Nro, INC. | $46.33 | 2025 | Prospera |
| Electronic Waveform Lab, INC. | $39.98 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $37.70 | 2019-2020 | |
| Vertos Medical, INC. | $36.71 | 2023 | Mild Device Kit |
| Lundbeck LLC | $33.21 | 2023 | Vyepti |
| International Rehabilitative Sciences, INC | $28.92 | 2024-2025 | Rs 4i Plus Sequential Stimulator |
| Nalu Medical, INC. | $23.32 | 2024 | Nalu Neurostimulation System |
| Axonics, INC. | $21.64 | 2023 | Axonics |
| Zimmer Biomet Holdings, INC. | $21.02 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.72 | 2023 | Seglentis |
| Pfizer INC. | $11.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.